Paul Truex Founder of Thryv Therapeutics Backed byFonds de solidarité FTQJanie Béïque SourcesThryv Therapeutics Announces FDA IND Clearance of THRV-1268 for Long QT Syndrome — 2025-09 Browse all founders · Browse investors